{"id":250,"date":"2014-12-24T15:34:20","date_gmt":"2014-12-24T06:34:20","guid":{"rendered":"http:\/\/www.whizp.com\/wordpress\/?page_id=250"},"modified":"2025-04-01T12:07:37","modified_gmt":"2025-04-01T03:07:37","slug":"fund","status":"publish","type":"page","link":"https:\/\/www.whizp.com\/old\/e\/fund\/","title":{"rendered":"Fund Information"},"content":{"rendered":"<div class=\"alpha_a content\">\n<div class=\"thick\">We introduce you the funds which are founded after 2010, Whiz Partners started to operate as an independent investment company.<\/p>\n<h3>Healthcare New Platform Fund Investment LP<\/h3>\n<p>The Healthcare New Platform fund serves as a booster fund for the Drug Discovery Gateway Fund Investment Limited Partnership, employing a hedging strategy through investment in Axcelead Inc. (hereafter referred to as &#8220;Axcelead&#8221;), which is nearing an IPO. In addition, the fund targets upside potential by investing in Axcelead Group companies, including ARCALIS Inc., which operates a GMP-compliant integrated mRNA pharmaceutical CDMO business, and IP Gaia Inc., which focuses on intellectual property acquisition and out-licensing for new pharmaceuticals.<\/p>\n<div class=\"fund_a marginb20\">\n<dl>\n<dt>Portfolio Companies<\/dt>\n<dd>\n<div class=\"logo_c\">\n<ul>\n<li><a href=\"https:\/\/www.axcelead-hd.com\/en-home\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1524\" title=\"Axcelead, Inc.\" src=\"https:\/\/www.whizp.com\/wp-content\/uploads\/2024\/11\/Axcelead-\u30ed\u30b4.png\" alt=\"Axcelead\" width=\"200\" height=\"63\" \/><\/a><\/li>\n<li><a href=\"https:\/\/corp.arcalis.co.jp\/en\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1525\" title=\"ARCALIS, Inc.\" src=\"https:\/\/www.whizp.com\/wp-content\/uploads\/2024\/11\/ARCALIS_logo_fix-01.png\" alt=\"ARCALIS\" width=\"160\" height=\"53\" \/><\/a><\/li>\n<li><a href=\"https:\/\/ip-g.com\/en\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2193\" title=\"IP Gaia, Inc.\" src=\"https:\/\/www.whizp.com\/wp-content\/uploads\/2024\/11\/IPG-22.06.24.png\" alt=\"IP Gaia\" width=\"130\" height=\"32\" \/><\/a><\/li>\n<li><a href=\"https:\/\/a-digital.co.jp\/en\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2193\" title=\"A-Digital, Inc.\" src=\"https:\/\/www.whizp.com\/wp-content\/uploads\/2024\/11\/logo_HorizontalType.png\" alt=\"A-Digital\" width=\"130\" height=\"32\" \/><\/a><\/li>\n<\/ul>\n<\/div>\n<\/dd>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"alpha_a content\">\n<div class=\"thick\">\n<h3>Whiz AIoT Evolution Fund Investment LP<\/h3>\n<p>Whiz AIoT Evolution Fund focuses on listed SMEs (Small and Medium-sized Enterprises), which can be expected to grow further by offering our digital transformation knowledge and AI technologies. We provide new money through convertible bond and warrant structure, and a full hands-on support to maximize the growth potential and corporate value of such firms.<\/p>\n<div class=\"fund_a marginb20\">\n<dl>\n<dt>Portfolio Companies<\/dt>\n<dd>\n<div class=\"logo_c\">\n<ul>\n<li><a title=\"AXELMARK INC.\" href=\"https:\/\/www.axelmark.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1524\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/axelmark_logo.png\" alt=\"\" width=\"200\" height=\"63\" \/><\/a><\/li>\n<li><a title=\"CRI Middleware Co., Ltd.\" href=\"https:\/\/www.cri-mw.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1545 size-full\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/criware_logo2.png\" alt=\"\" width=\"117\" height=\"84\" \/><\/a><\/li>\n<li><a href=\"https:\/\/dwti.co.jp\/english\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2193\" title=\"D. Western Therapeutics Institute, Inc.\" src=\"https:\/\/www.whizp.com\/wp-content\/uploads\/2023\/03\/DWTI_logo.png\" alt=\"D. Western Therapeutics Institute, Inc.\" width=\"110\" height=\"32\" srcset=\"https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2023\/03\/DWTI_logo.png 400w, https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2023\/03\/DWTI_logo-300x86.png 300w\" sizes=\"auto, (max-width: 110px) 100vw, 110px\" \/><\/a><\/li>\n<li><a href=\"https:\/\/www.traas.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2195\" title=\"TRaaS On Product\" src=\"https:\/\/www.whizp.com\/wp-content\/uploads\/2023\/03\/Traas_OP_logo.png\" alt=\"TRaaS On Product\" width=\"100\" height=\"40\" srcset=\"https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2023\/03\/Traas_OP_logo.png 481w, https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2023\/03\/Traas_OP_logo-300x120.png 300w\" sizes=\"auto, (max-width: 100px) 100vw, 100px\" \/><\/a><\/li>\n<li><a href=\"https:\/\/www.shanon.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2196\" title=\"SHANON Inc.\" src=\"https:\/\/www.whizp.com\/wp-content\/uploads\/2023\/03\/SHANON_logo.png\" alt=\"SHANON Inc.\" width=\"150\" height=\"49\" \/><\/a><\/li>\n<\/ul>\n<\/div>\n<\/dd>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"alpha_a content\">\n<div class=\"thick\">\n<h3>Drug Discovery Gateway Fund Investment LP<\/h3>\n<p>The Drug Discovery Gateway Fund is a fund mainly focusing on its investment to Axcelead, Inc (\u201cAxcelead\u201d). Under the jurisdiction of Axcelead, Axcelead Drug Discovery Partners, Inc (\u201cADDP\u201d), a spin-off company from Takeda Pharmaceutical Co., Ltd., have developed a drug discovery platform business for most of Japanese pharmaceutical companies. The Axcelead Group is expanding its drug discovery platform, including medical devices, contract development and manufacturing business (CDMO) for a new drug modality, and drug discovery technology utilized artificial intelligence.<\/p>\n<div class=\"fund_a marginb20\">\n<dl>\n<dt>Portfolio Companies<\/dt>\n<dd>\n<div class=\"logo_c\">\n<ul>\n<li><a title=\"Axcelead Drug Discovery Partners\" href=\"https:\/\/www.axcelead.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1514\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/axcelead_logo-300x83.png\" alt=\"\" width=\"200\" height=\"55\" srcset=\"https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2021\/04\/axcelead_logo-300x83.png 300w, https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2021\/04\/axcelead_logo.png 601w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><\/li>\n<li><span class=\"none\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1516\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/sylvian_logo.png\" alt=\"\" width=\"180\" height=\"80\" \/><\/span><\/li>\n<li><a title=\"PassPort Technologies\" href=\"https:\/\/passport-tech.com\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1515 size-full\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/passport-tech_logo.png\" alt=\"\" width=\"125\" height=\"51\" \/><\/a><\/li>\n<li><a title=\"caresyntax\" href=\"https:\/\/caresyntax.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1517\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/caresyntax_logo.png\" alt=\"\" width=\"200\" height=\"67\" \/><\/a><\/li>\n<li><a title=\"ActualEyes Inc.\" href=\"https:\/\/www.actualeyes.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1518\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/actualeyes_logo.png\" alt=\"\" width=\"200\" height=\"33\" \/><\/a><\/li>\n<li><a title=\"Capital Medica Co.,Ltd.\" href=\"https:\/\/capimedi.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1519\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/capitalmedica_logo.jpg\" alt=\"\" width=\"200\" height=\"41\" \/><\/a><\/li>\n<\/ul>\n<\/div>\n<\/dd>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"alpha_a content\">\n<div class=\"thick\">\n<h3>Whiz Asia Evolution Fund Investment Limited Partnership<\/h3>\n<p>There are numerous firms in Japan with wondrous technologies and services that draw in the world. We established the Whiz Asia Evolution Fund to maximize the growth potential and corporate value of such firms by connecting them to the growing Asian markets through our domestic and overseas network.<\/p>\n<div class=\"fund_a marginb20\">\n<dl>\n<dt>Portfolio Companies<\/dt>\n<dd>\n<div class=\"logo_c\">\n<ul>\n<li><a title=\"Advanced Media\" href=\"http:\/\/www.advanced-media.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1195\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_03.png\" alt=\"\" width=\"80\" height=\"69\" \/><\/a><\/li>\n<li><a title=\"Shobunsha Publications, Inc.\" href=\"http:\/\/www.mapple.co.jp\/corporate\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1196\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_04.png\" alt=\"\" width=\"148\" height=\"33\" \/><\/a><\/li>\n<li><a title=\"CRI Middleware\" href=\"http:\/\/www.cri-mw.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1197\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_06.png\" alt=\"\" width=\"100\" height=\"86\" \/><\/a><\/li>\n<li><a title=\"\" href=\"https:\/\/www.digitalhearts-hd.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1338\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/07\/76_05.gif\" alt=\"\" width=\"130\" height=\"84\" \/><\/a><\/li>\n<li><a href=\"http:\/\/www.albert2005.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1194\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_02.gif\" alt=\"\" width=\"140\" height=\"53\" \/><\/a><\/li>\n<li><span class=\"none\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1334\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/06\/image8.png\" alt=\"\" width=\"149\" height=\"47\" \/><\/span><\/li>\n<\/ul>\n<\/div>\n<\/dd>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"alpha_a content\">\n<div class=\"thick\">\n<h3>THE KENKO FUTURE Investment Limited Partnership<\/h3>\n<p>In addition to the bio-venture firms that were the investment targets for the first fund, the Partnership shall expand the investment universe to include private and publicly traded healthcare firms and healthcare divisions of publicly traded firms. The General Partner shall maximize equity value of the portfolio firms through management support thereby contributing to society by \u2018increasing competitive advantage and stimulating the entirety of the rapidly transforming Japanese Healthcare industry.\u2019<br \/>\nWe succeeded, and we consider ourselves fully prepared to leverage our legacy strength in life sciences and capture the investment opportunities in the wider field of healthcare through The Kenko Future Fund.<\/p>\n<div class=\"fund_a marginb20\">\n<dl>\n<dt>Portfolio Companies<\/dt>\n<dd>\n<div class=\"logo_c\">\n<ul>\n<li><a title=\"INSPEC INC.\" href=\"http:\/\/www.inspec21.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1300\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/04\/76_04.gif\" alt=\"\" width=\"160\" height=\"44\" \/><\/a><\/li>\n<li><a title=\"\" href=\"http:\/\/www.pathimaging.jp\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignnone size-full wp-image-1333\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/06\/image7.png\" alt=\"\" width=\"180\" \/><\/a><\/li>\n<li><a title=\"\" href=\"https:\/\/www.ribomic.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignnone size-full wp-image-1331\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/06\/image5.jpeg\" alt=\"\" width=\"170\" srcset=\"https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2018\/06\/image5.jpeg 341w, https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2018\/06\/image5-300x49.jpeg 300w\" sizes=\"(max-width: 341px) 100vw, 341px\" \/><\/a><\/li>\n<li><a title=\"\" href=\"https:\/\/whill.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1356\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/08\/76_09.png\" alt=\"\" width=\"103\" height=\"60\" \/><\/a><\/li>\n<\/ul>\n<\/div>\n<\/dd>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"alpha_a content\">\n<div class=\"thick\">\n<h3>Whiz HealthCare Japan 2.0 Investment Limited Partnership<\/h3>\n<p>As the era of blockbuster pharmaceuticals enters its twilight, healthcare faces a period of significant change. A new chapter is opening, and the best professionals will shift about before settling into their new homes. Japan was never known for globally dominant healthcare companies, but if we take this opportunity and focus People, Capital, and Knowledge, on the \u201cright\u201d firms, we may witness the birth of a Japanese firm who can shoulder the growth of tomorrow\u2019s healthcare.<br \/>\nJapan leads the world as an aging country, and medical services and products that are competitive in Japan can compete anywhere in the world. If we can create an ecosystem to effectively harness Japan\u2019s innovating capacity, we believe we can transform Japan to become a major Exporter of Wellness\u2019 in the world economy.<\/p>\n<div class=\"fund_a marginb20\">\n<dl>\n<dt>Portfolio Companies<\/dt>\n<dd>\n<div class=\"logo_c\">\n<ul>\n<li><a title=\"\" href=\"http:\/\/www.nanocarrier.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1184\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_00.png\" alt=\"\" width=\"148\" height=\"22\" \/><\/a><\/li>\n<li><a title=\"\" href=\"https:\/\/www.medinet-inc.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1190\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_05.png\" alt=\"\" width=\"177\" height=\"38\" \/><\/a><\/li>\n<li><a title=\"\" href=\"http:\/\/www.symbiopharma.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1186\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_02.png\" alt=\"\" width=\"114\" height=\"38\" \/><\/a><\/li>\n<li><a title=\"\" href=\"http:\/\/www.medrx.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1189\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_01.gif\" alt=\"\" width=\"140\" height=\"55\" \/><\/a><\/li>\n<li><a title=\"\" href=\"http:\/\/www.fronteo.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1191\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_07.png\" alt=\"\" width=\"160\" height=\"41\" \/><\/a><\/li>\n<li><a title=\"\" href=\"http:\/\/www.ibl-japan.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1192\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_08.png\" alt=\"\" width=\"100\" height=\"32\" \/><\/a><\/li>\n<li><a title=\"Forte Biosciences.Inc\" href=\"https:\/\/www.fortebiorx.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1553\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2021\/04\/forte_biosciences_logo.jpeg\" alt=\"\" width=\"230\" height=\"29\" srcset=\"https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2021\/04\/forte_biosciences_logo.jpeg 420w, https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2021\/04\/forte_biosciences_logo-300x38.jpeg 300w\" sizes=\"auto, (max-width: 230px) 100vw, 230px\" \/><\/a><\/li>\n<li><a title=\"\" href=\"https:\/\/www.ribomic.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignnone size-full wp-image-1331\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/06\/image5.jpeg\" alt=\"\" width=\"170\" srcset=\"https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2018\/06\/image5.jpeg 341w, https:\/\/www.whizp.com\/old\/wp-content\/uploads\/2018\/06\/image5-300x49.jpeg 300w\" sizes=\"(max-width: 341px) 100vw, 341px\" \/><\/a><\/li>\n<li><a title=\"\" href=\"https:\/\/whill.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1356\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/08\/76_09.png\" alt=\"\" width=\"103\" height=\"60\" \/><\/a><\/li>\n<\/ul>\n<\/div>\n<\/dd>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"alpha_a content\">\n<div class=\"thick\">\n<h3>Whiz Healthcare PE 1 Investment Limited Partnership<\/h3>\n<p>HealthCare \u2013 a high value creating industry, critical for the future of Japan. Public bio-venture firms play a crucial role in this industry, but we notice most bio-ventures lack the deep pockets necessary to last through the development costs. We believed that providing the necessary financing would enable such firms with innovative technology to flourish. We pursued our belief by establishing the Whiz HealthCare PE Series 1 fund, hoping to stimulate the Japanese bio-venture industry.<\/p>\n<div class=\"fund_a marginb20\">\n<dl>\n<dt>Portfolio Companies<\/dt>\n<dd>\n<div class=\"logo_c\">\n<ul>\n<li><a title=\"NanoCarrier\" href=\"http:\/\/www.nanocarrier.co.jp\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1184\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_00.png\" alt=\"\" width=\"148\" height=\"22\" \/><\/a><\/li>\n<li><a title=\"GENE TECHNO SCIENCE\" href=\"http:\/\/www.g-gts.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1185\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_01.png\" alt=\"\" width=\"76\" height=\"70\" \/><\/a><\/li>\n<li><a title=\"SymBio Pharmaceuticals\" href=\"http:\/\/www.symbiopharma.com\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1186\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2014\/12\/76_02.png\" alt=\"\" width=\"114\" height=\"38\" \/><\/a><\/li>\n<li><a title=\"\" href=\"https:\/\/www.cellseed.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignnone size-full wp-image-1329\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/06\/image2.gif\" alt=\"\" width=\"170\" \/><\/a><\/li>\n<li><a title=\"\" href=\"http:\/\/www.nanodex.jp\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignnone size-full wp-image-1328\" src=\"http:\/\/www.whizp.com\/wp-content\/uploads\/2018\/06\/image3.gif\" alt=\"\" width=\"190\" \/><\/a><\/li>\n<\/ul>\n<\/div>\n<\/dd>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<p><!-- div class=\"alpha_a content\">\n\n\n<div class=\"thick\">\n\n\n<h3>Whiz Rock Global Macro Investment Fund<\/h3>\n\n\nWe are most likely the only Global Macro Hedge Fund in Japan now. The Fund invests in futures, etc. to achieve stable returns under any market conditions based on macro analysis and market environment analysis. We didn\u2019t want to restrict ourselves to \u2018Grand Slam\u2019 home runs, but also to obtain \u2018single base\u2019 hits even when times are rough. We have a natural strength in Japanese Yen trading and appreciate our fans, domestic and overseas.\n\n\n<div class=\"fund_a marginb20\">\n\n\n<dl>\n \t\n\n<dt>Fund Manager<\/dt>\n\n\n \t\n\n<dd>\n\n\n<div class=\"border\">Naoki Iwami, Executive Vice President &amp; CIO<\/div>\n\n<\/dd>\n\n\n<\/dl>\n\n\n<\/div>\n\n\n<\/div>\n\n\n<\/div --> *Investment management of this Fund is delegated to Whiz Partners, but Whiz Partners has not engaged in any offering and any dealing in the offering of the Fund.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We introduce you the funds which are founded after 2010, Whiz Partners started to operate as an independent in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":12,"menu_order":16,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-250","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/pages\/250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/comments?post=250"}],"version-history":[{"count":26,"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/pages\/250\/revisions"}],"predecessor-version":[{"id":2567,"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/pages\/250\/revisions\/2567"}],"up":[{"embeddable":true,"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/pages\/12"}],"wp:attachment":[{"href":"https:\/\/www.whizp.com\/old\/wp-json\/wp\/v2\/media?parent=250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}